
Healthcare / Medical Supplies · BSE
Founded in October 2007, Amkay Products Limited is a well-known name in India’s healthcare industry, manufacturing and supplying a wide range of medical products. Their offerings include medical devices like nebulizers and pulse oximeters, as well as disposable essentials such as face masks and alcohol swabs. Amkay’s 26,000 sq. ft. manufacturing facility in Thane, Maharashtra, is equipped with advanced machinery, a modern testing lab, and efficient handling equipment, ensuring smooth and high-quality production. The company’s strong focus on quality has earned it ISO 9001:2015 certification from QRO Certification LLP. As of December 31, 2023, Amkay employs 75 dedicated professionals, reflecting its commitment to building a skilled workforce. Despite the ever-changing healthcare landscape, the company remains focused on innovation, quality, and customer satisfaction, playing a key role in meeting healthcare needs across India.
Price Band
₹52 – ₹55
Issue Size
₹12.61 Cr
Lot Size
2000 shares
GMP
+112.7%
Est. Listing
₹117
at current GMP
Subscribed
748.11x
overall
Open
30 Apr 2024
Close
3 May 2024
Allotment
6 May 2024
Refund
7 May 2024
Demat Credit
8 May 2024
Listing
8 May 2024
Overall Subscription
748.11x
Total Demand
QIB Multiplier
173.04x
Institutions & Funds
NII / HNI
987.71x
High Net-Worth
Retail (RII)
973.14x
Individual Bidders
Live bidding breakdown by institutional, non-institutional, and retail investors
| Category | Shares Offered | Shares Applied / Bid | Times Subscribed |
|---|---|---|---|
| QIB | 434,000 | 75,098,000 | 173.04x |
| NIB | 326,000 | 321,994,000 | 987.71x |
| RETAIL | 762,000 | 741,530,000 | 973.14x |
| Total | 1,522,000 | 1,138,622,000 | 748.11x |
Total unique applications received across retail and HNI tranches
| Category | Applications Reserved | Applications Received | Times Subscribed |
|---|---|---|---|
| Retail (RII) | 401 | 390,229 | 973.14x |
| HNIs (10L +) | 3 | 2,963 | 987.71x |
| HNIs (2-10L) | 12 | 11,853 | 987.71x |
| Total Applications | 416 | 405,045 | 973.67x |
Track continuous institutional and retail bidding order books for all active issues on the ipo live subscription feed.
Amkay Products Limited is bringing an initial public offering (IPO) in the Healthcare / Medical Supplies sector with an aggregate issue size of ₹12.61 Crores. The shares are offered at a price band of ₹52 to ₹55 per equity share on BSE. Currently, investors are tracking the grey market premium (GMP) and institutional subscription multiples closely across BSE and NSE portals.
The public offer consists of a fresh issue and offer-for-sale structured under SEBI regulations. Bidding is open to Qualified Institutional Buyers (QIB), Non-Institutional Bidders (NII/HNI), and Retail Individual Investors (RII). Applications can be submitted online using ASBA or UPI mandate through certified stock brokers and net banking portals.
Following the close of bidding on 2024-05-03, the basis of allotment is scheduled to be finalized on 2024-05-06. Investors can verify their application status online by submitting their PAN card number, Application Number, or DP Client ID on the registrar's official portal (Bigshare Services Private Limited) or the BSE allotment checking window.
The latest Grey Market Premium (GMP) for Amkay Products Limited IPO is ₹62 per equity share. Based on the upper price band of ₹52 to ₹55 per equity share, the estimated listing price is ₹117 (+112.7% expected listing gain).
With a lot size of 2000 shares and current GMP of ₹62, the expected profit per application lot is approx ₹1,24,000 (+112.7% gain). Minimum application cost is approx ₹1,10,000.
The Amkay Products Limited IPO aggregate issue size is ₹12.61 Crores with an equity price band set at ₹52 to ₹55 per equity share. The retail lot size is 2000 shares requiring a minimum capital outlay of approx. ₹1,10,000.
Live subscription figures are compiled real-time from the NSE and BSE bidding engines. Currently, overall subscription is 748.11x (Retail: 973.14x, QIB: 173.04x, NII: 987.71x). You can track live multiples directly on our dedicated subscription page.
The basis of allotment will be published on the official registrar portal (Bigshare Services Private Limited) and the BSE status verification website on or around 2024-05-06. Investors can verify status using PAN card or application number.
Amkay Products Limited shares are scheduled to list on BSE on 2024-05-08.